Medical

Cardiff Research Areas

Subordinate Areas

• Blood
  • Underpinning Research (Blood)
    • Normal biological development and functioning (Blood)
    • Psychological and socioeconomic processes (Blood)
    • Chemical and physical sciences (Blood)
    • Methodologies and measurements (Blood)
    • Resources and infrastructure (underpinning) (Blood)
  • Aetiology (Blood)
    • Biological and endogenous factors (Blood)
    • Factors relating to physical environment (Blood)
    • Psychological social and economic factors (Blood)
    • Surveillance and distribution (Blood)
    • Research design and methodologies (Blood)
    • Resources and infrastructure (aetiology) (Blood)
  • Prevention of Disease and Conditions and Promotion of Well-being (Blood)
    • Primary prevention interventions to modify behaviours or promote well-being (Blood)
    • Interventions to alter physical and biological environmental risks (Blood)
    • Nutrition and chemoprevention (Blood)
    • Vaccines (Blood)
    • Resources and infrastructure (prevention) (Blood)
  • Detection Screening and Diagnosis (Blood)
    • Discovery and preclinical testing of markers and technologies (Blood)
    • Evaluation of markers and technologies (Blood)
    • Influences and impact (Blood)
    • Population screening (Blood)
    • Resources and infrastructure (detection) (Blood)
  • Development of Treatments and Therapeutic Interventions (Blood)
    • Pharmaceuticals (Blood)
    • Cellular and gene therapies (Blood)
    • Medical devices (Blood)
    • Surgery (Blood)
    • Radiotherapy (Blood)
    • Psychological and behavioural (Blood)
    • Physical (Blood)
    • Complementary (Blood)
    • Resources and infrastrcuture (Development) (Blood)
  • Evaluation of Treatments and Therapeutic Interventions (Blood)
    • Pharmaceuticals (Blood)
    • Cellular and gene therapies (Blood)
    • Medical devices (Blood)
    • Surgery (Blood)
    • Radiotherapy (Blood)
    • Psychological and behavioural (Blood)
    • Physical (Blood)
    • Complementary (Blood)
    • Resources and infrastrcuture (Evaluation) (Blood)
  • Management of Diseases and Conditions (Blood)
    • Individual care needs (Blood)
    • End of life care (Blood)
    • Management and decision making (Blood)
    • Resources and infrastructure (Management) (Blood)
  • Health and Social Care Services Research (Blood)
    • Organisation and delivery of services (Blood)
    • Healthe and welfare economics (Blood)
    • Policy ethics and research governance (Blood)
    • Research design and methodologies (Blood)
    • Resources and infrastructure (Blood)
• Cancer
  • Underpinning Research (Cancer)
    • Normal biological development and functioning (Cancer)
    • Psychological and socioeconomic processes (Cancer)
    • Chemical and physical sciences (Cancer)
    • Methodologies and measurements (Cancer)
    • Resources and infrastructure (underpinning) (Cancer)
  • Aetiology (Cancer)
    • Biological and endogenous factors (Cancer)
    • Factors relating to physical environment (Cancer)
    • Psychological social and economic factors (Cancer)
    • Surveillance and distribution (Cancer)
    • Research design and methodologies (Cancer)
    • Resources and infrastructure (aetiology) (Cancer)
  • Prevention of Disease and Conditions and Promotion of Well-being (Cancer)
    • Primary prevention interventions to modify behaviours or promote well-being (Cancer)
    • Interventions to alter physical and biological environmental risks (Cancer)
    • Nutrition and chemoprevention (Cancer)
    • Vaccines (Cancer)
    • Resources and infrastructure (prevention) (Cancer)
  • Detection Screening and Diagnosis (Cancer)
    • Discovery and preclinical testing of markers and technologies (Cancer)
    • Evaluation of markers and technologies (Cancer)
    • Influences and impact (Cancer)
    • Population screening (Cancer)
    • Resources and infrastructure (detection) (Cancer)
  • Development of Treatments and Therapeutic Interventions (Cancer)
    • Pharmaceuticals (Cancer)
    • Cellular and gene therapies (Cancer)
    • Medical devices (Cancer)
    • Surgery (Cancer)
    • Radiotherapy (Cancer)
    • Psychological and behavioural (Cancer)
    • Physical (Cancer)
    • Complementary (Cancer)
    • Resources and infrastrcuture (Development) (Cancer)
  • Evaluation of Treatments and Therapeutic Interventions (Cancer)
    • Pharmaceuticals (Cancer)
    • Cellular and gene therapies (Cancer)
    • Medical devices (Cancer)
    • Surgery (Cancer)
    • Radiotherapy (Cancer)
    • Psychological and behavioural (Cancer)
    • Physical (Cancer)
    • Complementary (Cancer)
    • Resources and infrastrcuture (Evaluation) (Cancer)
  • Management of Diseases and Conditions (Cancer)
    • Individual care needs (Cancer)
    • End of life care (Cancer)
    • Management and decision making (Cancer)
    • Resources and infrastructure (Management) (Cancer)
  • Health and Social Care Services Research (Cancer)
    • Organisation and delivery of services (Cancer)
    • Healthe and welfare economics (Cancer)
    • Policy ethics and research governance (Cancer)
    • Research design and methodologies (Cancer)
    • Resources and infrastructure (Cancer)
• Cardiovascular
  • Underpinning Research (Cardio)
    • Normal biological development and functioning (Cardio)
    • Psychological and socioeconomic processes (Cardio)
    • Chemical and physical sciences (Cardio)
    • Methodologies and measurements (Cardio)
    • Resources and infrastructure (underpinning) (Cardio)
  • Aetiology (Cardio)
    • Biological and endogenous factors (Cardio)
    • Factors relating to physical environment (Cardio)
    • Psychological social and economic factors (Cardio)
    • Surveillance and distribution (Cardio)
    • Research design and methodologies (Cardio)
    • Resources and infrastructure (aetiology) (Cardio)
  • Prevention of Disease and Conditions and Promotion of Well-being (Cardio)
    • Primary prevention interventions to modify behaviours or promote well-being (Cardio)
    • Interventions to alter physical and biological environmental risks (Cardio)
    • Nutrition and chemoprevention (Cardio)
    • Vaccines (Cardio)
    • Resources and infrastructure (prevention) (Cardio)
  • Detection Screening and Diagnosis (Cardio)
    • Discovery and preclinical testing of markers and technologies (Cardio)
    • Evaluation of markers and technologies (Cardio)
    • Influences and impact (Cardio)
    • Population screening (Cardio)
    • Resources and infrastructure (detection) (Cardio)
  • Development of Treatments and Therapeutic Interventions (Cardio)
    • Pharmaceuticals (Cardio)
    • Cellular and gene therapies (Cardio)
    • Medical devices (Cardio)
    • Surgery (Cardio)
    • Radiotherapy (Cardio)
    • Psychological and behavioural (Cardio)
    • Physical (Cardio)
    • Complementary (Cardio)
    • Resources and infrastrcuture (Development) (Cardio)
  • Evaluation of Treatments and Therapeutic Interventions (Cardio)
    • Pharmaceuticals (Cardio)
    • Cellular and gene therapies (Cardio)
    • Medical devices (Cardio)
    • Surgery (Cardio)
    • Radiotherapy (Cardio)
    • Psychological and behavioural (Cardio)
    • Physical (Cardio)
    • Complementary (Cardio)
    • Resources and infrastrcuture (Evaluation) (Cardio)
  • Management of Diseases and Conditions (Cardio)
    • Individual care needs (Cardio)
    • End of life care (Cardio)
    • Management and decision making (Cardio)
    • Resources and infrastructure (Management) (Cardio)
  • Health and Social Care Services Research (Cardio)
    • Organisation and delivery of services (Cardio)
    • Healthe and welfare economics (Cardio)
    • Policy ethics and research governance (Cardio)
    • Research design and methodologies (Cardio)
    • Resources and infrastructure (Cardio)
• Congenital Disorders
  • Underpinning Research (ConDis)
    • Normal biological development and functioning (ConDis)
    • Psychological and socioeconomic processes (ConDis)
    • Chemical and physical sciences (ConDis)
    • Methodologies and measurements (ConDis)
    • Resources and infrastructure (underpinning) (ConDis)
  • Aetiology (ConDis)
    • Biological and endogenous factors (ConDis)
    • Factors relating to physical environment (ConDis)
    • Psychological social and economic factors (ConDis)
    • Surveillance and distribution (ConDis)
    • Research design and methodologies (ConDis)
    • Resources and infrastructure (aetiology) (ConDis)
  • Prevention of Disease and Conditions and Promotion of Well-being (ConDis)
    • Primary prevention interventions to modify behaviours or promote well-being (ConDis)
    • Interventions to alter physical and biological environmental risks (ConDis)
    • Nutrition and chemoprevention (ConDis)
    • Vaccines (ConDis)
    • Resources and infrastructure (prevention) (ConDis)
  • Detection Screening and Diagnosis (ConDis)
    • Discovery and preclinical testing of markers and technologies (ConDis)
    • Evaluation of markers and technologies (ConDis)
    • Influences and impact (ConDis)
    • Population screening (ConDis)
    • Resources and infrastructure (detection) (ConDis)
  • Development of Treatments and Therapeutic Interventions (ConDis)
    • Pharmaceuticals (ConDis)
    • Cellular and gene therapies (ConDis)
    • Medical devices (ConDis)
    • Surgery (ConDis)
    • Radiotherapy (ConDis)
    • Psychological and behavioural (ConDis)
    • Physical (ConDis)
    • Complementary (ConDis)
    • Resources and infrastrcuture (Development) (ConDis)
  • Evaluation of Treatments and Therapeutic Interventions (ConDis)
    • Pharmaceuticals (ConDis)
    • Cellular and gene therapies (ConDis)
    • Medical devices (ConDis)
    • Surgery (ConDis)
    • Radiotherapy (ConDis)
    • Psychological and behavioural (ConDis)
    • Physical (ConDis)
    • Complementary (ConDis)
    • Resources and infrastrcuture (Evaluation) (ConDis)
  • Management of Diseases and Conditions (ConDis)
    • Individual care needs (ConDis)
    • End of life care (ConDis)
    • Management and decision making (ConDis)
    • Resources and infrastructure (Management) (ConDis)
  • Health and Social Care Services Research (ConDis)
    • Organisation and delivery of services (ConDis)
    • Healthe and welfare economics (ConDis)
    • Policy ethics and research governance (ConDis)
    • Research design and methodologies (ConDis)
    • Resources and infrastructure (health services) (ConDis)
• Ear
  • Underpinning Research (Ear)
    • Normal biological development and functioning (Ear)
    • Psychological and socioeconomic processes (Ear)
    • Chemical and physical sciences (Ear)
    • Methodologies and measurements (Ear)
    • Resources and infrastructure (underpinning) (Ear)
  • Aetiology (Ear)
    • Biological and endogenous factors (Ear)
    • Factors relating to physical environment (Ear)
    • Psychological social and economic factors (Ear)
    • Surveillance and distribution (Ear)
    • Research design and methodologies (Ear)
    • Resources and infrastructure (aetiology) (Ear)
  • Prevention of Disease and Conditions and Promotion of Well-being (Ear)
    • Primary prevention interventions to modify behaviours or promote well-being (Ear)
    • Interventions to alter physical and biological environmental risks (Ear)
    • Nutrition and chemoprevention (Ear)
    • Vaccines (Ear)
    • Resources and infrastructure (prevention) (Ear)
  • Detection Screening and Diagnosis (Ear)
    • Discovery and preclinical testing of markers and technologies (Ear)
    • Evaluation of markers and technologies (Ear)
    • Influences and impact (Ear)
    • Population screening (Ear)
    • Resources and infrastructure (detection) (Ear)
  • Development of Treatments and Therapeutic Interventions (Ear)
    • Pharmaceuticals (Ear)
    • Cellular and gene therapies (Ear)
    • Medical devices (Ear)
    • Surgery (Ear)
    • Radiotherapy (Ear)
    • Psychological and behavioural (Ear)
    • Physical (Ear)
    • Complementary (Ear)
    • Resources and infrastrcuture (development) (Ear)
  • Evaluation of Treatments and Therapeutic Interventions (Ear)
    • Pharmaceuticals (Ear)
    • Cellular and gene therapies (Ear)
    • Medical devices (Ear)
    • Surgery (Ear)
    • Radiotherapy (Ear)
    • Psychological and behavioural (Ear)
    • Physical (Ear)
    • Complementary (Ear)
    • Resources and infrastrcuture (evaluation) (Ear)
  • Management of Diseases and Conditions (Ear)
    • Individual care needs (Ear)
    • End of life care (Ear)
    • Management and decision making (Ear)
    • Resources and infrastructure (management) (Ear)
  • Health and Social Care Services Research (Ear)
    • Organisation and delivery of services (Ear)
    • Healthe and welfare economics (Ear)
    • Policy ethics and research governance (Ear)
    • Research design and methodologies (Ear)
    • Resources and infrastructure (health services) (Ear)
• Eye
  • Underpinning Research (Eye)
    • Normal biological development and functioning (Eye)
    • Psychological and socioeconomic processes (Eye)
    • Chemical and physical sciences (Eye)
    • Methodologies and measurements (Eye)
    • Resources and infrastructure (underpinning) (Eye)
  • Aetiology (Eye)
    • Biological and endogenous factors (Eye)
    • Factors relating to physical environment (Eye)
    • Psychological social and economic factors (Eye)
    • Surveillance and distribution (Eye)
    • Research design and methodologies (Eye)
    • Resources and infrastructure (aetiology) (Eye)
  • Prevention of Disease and Conditions and Promotion of Well-being (Eye)
    • Primary prevention interventions to modify behaviours or promote well-being (Eye)
    • Interventions to alter physical and biological environmental risks (Eye)
    • Nutrition and chemoprevention (Eye)
    • Vaccines (Eye)
    • Resources and infrastructure (prevention) (Eye)
  • Detection Screening and Diagnosis (Eye)
    • Discovery and preclinical testing of markers and technologies (Eye)
    • Evaluation of markers and technologies (Eye)
    • Influences and impact (Eye)
    • Population screening (Eye)
    • Resources and infrastructure (detection) (Eye)
  • Development of Treatments and Therapeutic Interventions (Eye)
    • Pharmaceuticals (Eye)
    • Cellular and gene therapies (Eye)
    • Medical devices (Eye)
    • Surgery (Eye)
    • Radiotherapy (Eye)
    • Psychological and behavioural (Eye)
    • Physical (Eye)
    • Complementary (Eye)
    • Resources and infrastrcuture (development) (Eye)
  • Evaluation of Treatments and Therapeutic Interventions (Eye)
    • Pharmaceuticals (Eye)
    • Cellular and gene therapies (Eye)
    • Medical devices (Eye)
    • Surgery (Eye)
    • Radiotherapy (Eye)
    • Psychological and behavioural (Eye)
    • Physical (Eye)
    • Complementary (Eye)
    • Resources and infrastrcuture (evaluation) (Eye)
  • Management of Diseases and Conditions (Eye)
    • Individual care needs (Eye)
    • End of life care (Eye)
    • Management and decision making (Eye)
    • Resources and infrastructure (management) (Eye)
  • Health and Social Care Services Research (Eye)
    • Organisation and delivery of services (Eye)
    • Healthe and welfare economics (Eye)
    • Policy ethics and research governance (Eye)
    • Research design and methodologies (Eye)
    • Resources and infrastructure (health services) (Eye)
• Infection
  • Underpinning Research (Infec)
    • Normal biological development and functioning (Infec)
    • Psychological and socioeconomic processes (Infec)
    • Chemical and physical sciences (Infec)
    • Methodologies and measurements (Infec)
    • Resources and infrastructure (underpinning) (Infec)
  • Aetiology (Infec)
    • Biological and endogenous factors (Infec)
    • Factors relating to physical environment (Infec)
    • Psychological social and economic factors (Infec)
    • Surveillance and distribution (Infec)
    • Research design and methodologies (Infec)
    • Resources and infrastructure (aetiology) (Infec)
  • Prevention of Disease and Conditions and Promotion of Well-being (Infec)
    • Primary prevention interventions to modify behaviours or promote well-being (Infec)
    • Interventions to alter physical and biological environmental risks (Infec)
    • Nutrition and chemoprevention (Infec)
    • Vaccines (Infec)
    • Resources and infrastructure (prevention) (Infec)
  • Detection Screening and Diagnosis (Infec)
    • Discovery and preclinical testing of markers and technologies (Infec)
    • Evaluation of markers and technologies (Infec)
    • Influences and impact (Infec)
    • Population screening (Infec)
    • Resources and infrastructure (detection) (Infec)
  • Development of Treatments and Therapeutic Interventions (Infec)
    • Pharmaceuticals (Infec)
    • Cellular and gene therapies (Infec)
    • Medical devices (Infec)
    • Surgery (Infec)
    • Radiotherapy (Infec)
    • Psychological and behavioural (Infec)
    • Physical (Infec)
    • Complementary (Infec)
    • Resources and infrastrcuture (development) (Infec)
  • Evaluation of Treatments and Therapeutic Interventions (Infec)
    • Pharmaceuticals (Infec)
    • Cellular and gene therapies (Infec)
    • Medical devices (Infec)
    • Surgery (Infec)
    • Radiotherapy (Infec)
    • Psychological and behavioural (Infec)
    • Physical (Infec)
    • Complementary (Infec)
    • Resources and infrastrcuture (evaluation) (Infec)
  • Management of Diseases and Conditions (Infec)
    • Individual care needs (Infec)
    • End of life care (Infec)
    • Management and decision making (Infec)
    • Resources and infrastructure (management) (Infec)
  • Health and Social Care Services Research (Infec)
    • Organisation and delivery of services (Infec)
    • Healthe and welfare economics (Infec)
    • Policy ethics and research governance (Infec)
    • Research design and methodologies (Infec)
    • Resources and infrastructure (health services) (Infec)
• Inflammatory and Immune System
  • Underpinning Research (IaIs)
    • Normal biological development and functioning (IaIs)
    • Psychological and socioeconomic processes (IaIs)
    • Chemical and physical sciences (IaIs)
    • Methodologies and measurements (IaIs)
    • Resources and infrastructure (underpinning) (IaIs)
  • Aetiology (IaIs)
    • Biological and endogenous factors (IaIs)
    • Factors relating to physical environment (IaIs)
    • Psychological social and economic factors (IaIs)
    • Surveillance and distribution (IaIs)
    • Research design and methodologies (IaIs)
    • Resources and infrastructure (aetiology) (IaIs)
  • Prevention of Disease and Conditions and Promotion of Well-being (IaIs)
    • Primary prevention interventions to modify behaviours or promote well-being (IaIs)
    • Interventions to alter physical and biological environmental risks (IaIs)
    • Nutrition and chemoprevention (IaIs)
    • Vaccines (IaIs)
    • Resources and infrastructure (prevention) (IaIs)
  • Detection Screening and Diagnosis (IaIs)
    • Discovery and preclinical testing of markers and technologies (IaIs)
    • Evaluation of markers and technologies (IaIs)
    • Influences and impact (IaIs)
    • Population screening (IaIs)
    • Resources and infrastructure (detection) (IaIs)
  • Development of Treatments and Therapeutic Interventions (IaIs)
    • Pharmaceuticals (IaIs)
    • Cellular and gene therapies (IaIs)
    • Medical devices (IaIs)
    • Surgery (IaIs)
    • Radiotherapy (IaIs)
    • Psychological and behavioural (IaIs)
    • Physical (IaIs)
    • Complementary (IaIs)
    • Resources and infrastrcuture (development) (IaIs)
  • Evaluation of Treatments and Therapeutic Interventions (IaIs)
    • Pharmaceuticals (IaIs)
    • Cellular and gene therapies (IaIs)
    • Medical devices (IaIs)
    • Surgery (IaIs)
    • Radiotherapy (IaIs)
    • Psychological and behavioural (IaIs)
    • Physical (IaIs)
    • Complementary (IaIs)
    • Resources and infrastrcuture (evaluation) (IaIs)
  • Management of Diseases and Conditions (IaIs)
    • Individual care needs (IaIs)
    • End of life care (IaIs)
    • Management and decision making (IaIs)
    • Resources and infrastructure (management) (IaIs)
  • Health and Social Care Services Research (IaIs)
    • Organisation and delivery of services (IaIs)
    • Healthe and welfare economics (IaIs)
    • Policy ethics and research governance (IaIs)
    • Research design and methodologies (IaIs)
    • Resources and infrastructure (health services) (IaIs)
• Injuries and Accidents
  • Underpinning Research (IaA)
    • Normal biological development and functioning (IaA)
    • Psychological and socioeconomic processes (IaA)
    • Chemical and physical sciences (IaA)
    • Methodologies and measurements (IaA)
    • Resources and infrastructure (underpinning) (IaA)
  • Aetiology (IaA)
    • Biological and endogenous factors (IaA)
    • Factors relating to physical environment (IaA)
    • Psychological social and economic factors (IaA)
    • Surveillance and distribution (IaA)
    • Research design and methodologies (IaA)
    • Resources and infrastructure (aetiology) (IaA)
  • Prevention of Disease and Conditions and Promotion of Well-being (IaA)
    • Primary prevention interventions to modify behaviours or promote well-being (IaA)
    • Interventions to alter physical and biological environmental risks (IaA)
    • Nutrition and chemoprevention (IaA)
    • Vaccines (IaA)
    • Resources and infrastructure (prevention) (IaA)
  • Detection Screening and Diagnosis (IaA)
    • Discovery and preclinical testing of markers and technologies (IaA)
    • Evaluation of markers and technologies (IaA)
    • Influences and impact (IaA)
    • Population screening (IaA)
    • Resources and infrastructure (detection) (IaA)
  • Development of Treatments and Therapeutic Interventions (IaA)
    • Pharmaceuticals (IaA)
    • Cellular and gene therapies (IaA)
    • Medical devices (IaA)
    • Surgery (IaA)
    • Radiotherapy (IaA)
    • Psychological and behavioural (IaA)
    • Physical (IaA)
    • Complementary (IaA)
    • Resources and infrastrcuture (development) (IaA)
  • Evaluation of Treatments and Therapeutic Interventions (IaA)
    • Pharmaceuticals (IaA)
    • Cellular and gene therapies (IaA)
    • Medical devices (IaA)
    • Surgery (IaA)
    • Radiotherapy (IaA)
    • Psychological and behavioural (IaA)
    • Physical (IaA)
    • Complementary (IaA)
    • Resources and infrastrcuture (evaluation) (IaA)
  • Management of Diseases and Conditions (IaA)
    • Individual care needs (IaA)
    • End of life care (IaA)
    • Management and decision making (IaA)
    • Resources and infrastructure (management) (IaA)
  • Health and Social Care Services Research (IaA)
    • Organisation and delivery of services (IaA)
    • Healthe and welfare economics (IaA)
    • Policy ethics and research governance (IaA)
    • Research design and methodologies (IaA)
    • Resources and infrastructure (health services) (IaA)
• Mental Health
  • Underpinning Research (Mental)
    • Normal biological development and functioning (Mental)
    • Psychological and socioeconomic processes (Mental)
    • Chemical and physical sciences (Mental)
    • Methodologies and measurements (Mental)
    • Resources and infrastructure (underpinning) (Mental)
  • Aetiology (Mental)
    • Biological and endogenous factors (Mental)
    • Factors relating to physical environment (Mental)
    • Psychological social and economic factors (Mental)
    • Surveillance and distribution (Mental)
    • Research design and methodologies (Mental)
    • Resources and infrastructure (aetiology) (Mental)
  • Prevention of Disease and Conditions and Promotion of Well-being (Mental)
    • Primary prevention interventions to modify behaviours or promote well-being (Mental)
    • Interventions to alter physical and biological environmental risks (Mental)
    • Nutrition and chemoprevention (Mental)
    • Vaccines (Mental)
    • Resources and infrastructure (prevention) (Mental)
  • Detection Screening and Diagnosis (Mental)
    • Discovery and preclinical testing of markers and technologies (Mental)
    • Evaluation of markers and technologies (Mental)
    • Influences and impact (Mental)
    • Population screening (Mental)
    • Resources and infrastructure (detection) (Mental)
  • Development of Treatments and Therapeutic Interventions (Mental)
    • Pharmaceuticals (Mental)
    • Cellular and gene therapies (Mental)
    • Medical devices (Mental)
    • Surgery (Mental)
    • Radiotherapy (Mental)
    • Psychological and behavioural (Mental)
    • Physical (Mental)
    • Complementary (Mental)
    • Resources and infrastrcuture (development) (Mental)
  • Evaluation of Treatments and Therapeutic Interventions (Mental)
    • Pharmaceuticals (Mental)
    • Cellular and gene therapies (Mental)
    • Medical devices (Mental)
    • Surgery (Mental)
    • Radiotherapy (Mental)
    • Psychological and behavioural (Mental)
    • Physical (Mental)
    • Complementary (Mental)
    • Resources and infrastrcuture (evaluation) (Mental)
  • Management of Diseases and Conditions (Mental)
    • Individual care needs (Mental)
    • End of life care (Mental)
    • Management and decision making (Mental)
    • Resources and infrastructure (management) (Mental)
  • Health and Social Care Services Research (Mental)
    • Organisation and delivery of services (Mental)
    • Healthe and welfare economics (Mental)
    • Policy ethics and research governance (Mental)
    • Research design and methodologies (Mental)
    • Resources and infrastructure (health services) (Mental)
• Metabolic and Endocrine
  • Underpinning Research (MaE)
    • Normal biological development and functioning (MaE)
    • Psychological and socioeconomic processes (MaE)
    • Chemical and physical sciences (MaE)
    • Methodologies and measurements (MaE)
    • Resources and infrastructure (underpinning) (MaE)
  • Aetiology (MaE)
    • Biological and endogenous factors (MaE)
    • Factors relating to physical environment (MaE)
    • Psychological social and economic factors (MaE)
    • Surveillance and distribution (MaE)
    • Research design and methodologies (MaE)
    • Resources and infrastructure (aetiology) (MaE)
  • Prevention of Disease and Conditions and Promotion of Well-being (MaE)
    • Primary prevention interventions to modify behaviours or promote well-being (MaE)
    • Interventions to alter physical and biological environmental risks (MaE)
    • Nutrition and chemoprevention (MaE)
    • Vaccines (MaE)
    • Resources and infrastructure (prevention) (MaE)
  • Detection Screening and Diagnosis (MaE)
    • Discovery and preclinical testing of markers and technologies (MaE)
    • Evaluation of markers and technologies (MaE)
    • Influences and impact (MaE)
    • Population screening (MaE)
    • Resources and infrastructure (detection) (MaE)
  • Development of Treatments and Therapeutic Interventions (MaE)
    • Pharmaceuticals (MaE)
    • Cellular and gene therapies (MaE)
    • Medical devices (MaE)
    • Surgery (MaE)
    • Radiotherapy (MaE)
    • Psychological and behavioural (MaE)
    • Physical (MaE)
    • Complementary (MaE)
    • Resources and infrastrcuture (development) (MaE)
  • Evaluation of Treatments and Therapeutic Interventions (MaE)
    • Pharmaceuticals (MaE)
    • Cellular and gene therapies (MaE)
    • Medical devices (MaE)
    • Surgery (MaE)
    • Radiotherapy (MaE)
    • Psychological and behavioural (MaE)
    • Physical (MaE)
    • Complementary (MaE)
    • Resources and infrastrcuture (evaluation) (MaE)
  • Management of Diseases and Conditions (MaE)
    • Individual care needs (MaE)
    • End of life care (MaE)
    • Management and decision making (MaE)
    • Resources and infrastructure (management) (MaE)
  • Health and Social Care Services Research (MaE)
    • Organisation and delivery of services (MaE)
    • Healthe and welfare economics (MaE)
    • Policy ethics and research governance (MaE)
    • Research design and methodologies (MaE)
    • Resources and infrastructure (health services) (MaE)
• Musculoskeletal
  • Underpinning Research (Musculo)
    • Normal biological development and functioning (Musculo)
    • Psychological and socioeconomic processes (Musculo)
    • Chemical and physical sciences (Musculo)
    • Methodologies and measurements (Musculo)
    • Resources and infrastructure (underpinning) (Musculo)
  • Aetiology (Musculo)
    • Biological and endogenous factors (Musculo)
    • Factors relating to physical environment (Musculo)
    • Psychological social and economic factors (Musculo)
    • Surveillance and distribution (Musculo)
    • Research design and methodologies (Musculo)
    • Resources and infrastructure (aetiology) (Musculo)
  • Prevention of Disease and Conditions and Promotion of Well-being (Musculo)
    • Primary prevention interventions to modify behaviours or promote well-being (Musculo)
    • Interventions to alter physical and biological environmental risks (Musculo)
    • Nutrition and chemoprevention (Musculo)
    • Vaccines (Musculo)
    • Resources and infrastructure (prevention) (Musculo)
  • Detection Screening and Diagnosis (Musculo)
    • Discovery and preclinical testing of markers and technologies (Musculo)
    • Evaluation of markers and technologies (Musculo)
    • Influences and impact (Musculo)
    • Population screening (Musculo)
    • Resources and infrastructure (detection) (Musculo)
  • Development of Treatments and Therapeutic Interventions (Musculo)
    • Pharmaceuticals (Musculo)
    • Cellular and gene therapies (Musculo)
    • Medical devices (Musculo)
    • Surgery (Musculo)
    • Radiotherapy (Musculo)
    • Psychological and behavioural (Musculo)
    • Physical (Musculo)
    • Complementary (Musculo)
    • Resources and infrastrcuture (development) (Musculo)
  • Evaluation of Treatments and Therapeutic Interventions (Musculo)
    • Pharmaceuticals (Musculo)
    • Cellular and gene therapies (Musculo)
    • Medical devices (Musculo)
    • Surgery (Musculo)
    • Radiotherapy (Musculo)
    • Psychological and behavioural (Musculo)
    • Physical (Musculo)
    • Complementary (Musculo)
    • Resources and infrastrcuture (evaluation) (Musculo)
  • Management of Diseases and Conditions (Musculo)
    • Individual care needs (Musculo)
    • End of life care (Musculo)
    • Management and decision making (Musculo)
    • Resources and infrastructure (management) (Musculo)
  • Health and Social Care Services Research (Musculo)
    • Organisation and delivery of services (Musculo)
    • Healthe and welfare economics (Musculo)
    • Policy ethics and research governance (Musculo)
    • Research design and methodologies (Musculo)
    • Resources and infrastructure (health services) (Musculo)
• Neurological
  • Underpinning Research (Neuro)
    • Normal biological development and functioning (Neuro)
    • Psychological and socioeconomic processes (Neuro)
    • Chemical and physical sciences (Neuro)
    • Methodologies and measurements (Neuro)
    • Resources and infrastructure (underpinning) (Neuro)
  • Aetiology (Neuro)
    • Biological and endogenous factors (Neuro)
    • Factors relating to physical environment (Neuro)
    • Psychological social and economic factors (Neuro)
    • Surveillance and distribution (Neuro)
    • Research design and methodologies (Neuro)
    • Resources and infrastructure (aetiology) (Neuro)
  • Prevention of Disease and Conditions and Promotion of Well-being (Neuro)
    • Primary prevention interventions to modify behaviours or promote well-being (Neuro)
    • Interventions to alter physical and biological environmental risks (Neuro)
    • Nutrition and chemoprevention (Neuro)
    • Vaccines (Neuro)
    • Resources and infrastructure (prevention) (Neuro)
  • Detection Screening and Diagnosis (Neuro)
    • Discovery and preclinical testing of markers and technologies (Neuro)
    • Evaluation of markers and technologies (Neuro)
    • Influences and impact (Neuro)
    • Population screening (Neuro)
    • Resources and infrastructure (detection) (Neuro)
  • Development of Treatments and Therapeutic Interventions (Neuro)
    • Pharmaceuticals (Neuro)
    • Cellular and gene therapies (Neuro)
    • Medical devices (Neuro)
    • Surgery (Neuro)
    • Radiotherapy (Neuro)
    • Psychological and behavioural (Neuro)
    • Physical (Neuro)
    • Complementary (Neuro)
    • Resources and infrastrcuture (development) (Neuro)
  • Evaluation of Treatments and Therapeutic Interventions (Neuro)
    • Pharmaceuticals (Neuro)
    • Cellular and gene therapies (Neuro)
    • Medical devices (Neuro)
    • Surgery (Neuro)
    • Radiotherapy (Neuro)
    • Psychological and behavioural (Neuro)
    • Physical (Neuro)
    • Complementary (Neuro)
    • Resources and infrastrcuture (evaluation) (Neuro)
  • Management of Diseases and Conditions (Neuro)
    • Individual care needs (Neuro)
    • End of life care (Neuro)
    • Management and decision making (Neuro)
    • Resources and infrastructure (management) (Neuro)
  • Health and Social Care Services Research (Neuro)
    • Organisation and delivery of services (Neuro)
    • Healthe and welfare economics (Neuro)
    • Policy ethics and research governance (Neuro)
    • Research design and methodologies (Neuro)
    • Resources and infrastructure (health services) (Neuro)
• Oral and Gastrointestinal
  • Underpinning Research (OaG)
    • Normal biological development and functioning (OaG)
    • Psychological and socioeconomic processes (OaG)
    • Chemical and physical sciences (OaG)
    • Methodologies and measurements (OaG)
    • Resources and infrastructure (underpinning) (OaG)
  • Aetiology (OaG)
    • Biological and endogenous factors (OaG)
    • Factors relating to physical environment (OaG)
    • Psychological social and economic factors (OaG)
    • Surveillance and distribution (OaG)
    • Research design and methodologies (OaG)
    • Resources and infrastructure (aetiology) (OaG)
  • Prevention of Disease and Conditions and Promotion of Well-being (OaG)
    • Primary prevention interventions to modify behaviours or promote well-being (OaG)
    • Interventions to alter physical and biological environmental risks (OaG)
    • Nutrition and chemoprevention (OaG)
    • Vaccines (OaG)
    • Resources and infrastructure (prevention) (OaG)
  • Detection Screening and Diagnosis (OaG)
    • Discovery and preclinical testing of markers and technologies (OaG)
    • Evaluation of markers and technologies (OaG)
    • Influences and impact (OaG)
    • Population screening (OaG)
    • Resources and infrastructure (detection) (OaG)
  • Development of Treatments and Therapeutic Interventions (OaG)
    • Pharmaceuticals (OaG)
    • Cellular and gene therapies (OaG)
    • Medical devices (OaG)
    • Surgery (OaG)
    • Radiotherapy (OaG)
    • Psychological and behavioural (OaG)
    • Physical (OaG)
    • Complementary (OaG)
    • Resources and infrastrcuture (development) (OaG)
  • Evaluation of Treatments and Therapeutic Interventions (OaG)
    • Pharmaceuticals (OaG)
    • Cellular and gene therapies (OaG)
    • Medical devices (OaG)
    • Surgery (OaG)
    • Radiotherapy (OaG)
    • Psychological and behavioural (OaG)
    • Physical (OaG)
    • Complementary (OaG)
    • Resources and infrastrcuture (evaluation) (OaG)
  • Management of Diseases and Conditions (OaG)
    • Individual care needs (OaG)
    • End of life care (OaG)
    • Management and decision making (OaG)
    • Resources and infrastructure (management) (OaG)
  • Health and Social Care Services Research (OaG)
    • Organisation and delivery of services (OaG)
    • Healthe and welfare economics (OaG)
    • Policy ethics and research governance (OaG)
    • Research design and methodologies (OaG)
    • Resources and infrastructure (health services) (OaG)
• Renal and Urogenital
  • Underpinning Research (RaU)
    • Normal biological development and functioning (RaU)
    • Psychological and socioeconomic processes (RaU)
    • Chemical and physical sciences (RaU)
    • Methodologies and measurements (RaU)
    • Resources and infrastructure (underpinning) (RaU)
  • Aetiology (RaU)
    • Biological and endogenous factors (RaU)
    • Factors relating to physical environment (RaU)
    • Psychological social and economic factors (RaU)
    • Surveillance and distribution (RaU)
    • Research design and methodologies (RaU)
    • Resources and infrastructure (aetiology) (RaU)
  • Prevention of Disease and Conditions and Promotion of Well-being (RaU)
    • Primary prevention interventions to modify behaviours or promote well-being (RaU)
    • Interventions to alter physical and biological environmental risks (RaU)
    • Nutrition and chemoprevention (RaU)
    • Vaccines (RaU)
    • Resources and infrastructure (prevention) (RaU)
  • Detection Screening and Diagnosis (RaU)
    • Discovery and preclinical testing of markers and technologies (RaU)
    • Evaluation of markers and technologies (RaU)
    • Influences and impact (RaU)
    • Population screening (RaU)
    • Resources and infrastructure (detection) (RaU)
  • Development of Treatments and Therapeutic Interventions (RaU)
    • Pharmaceuticals (RaU)
    • Cellular and gene therapies (RaU)
    • Medical devices (RaU)
    • Surgery (RaU)
    • Radiotherapy (RaU)
    • Psychological and behavioural (RaU)
    • Physical (RaU)
    • Complementary (RaU)
    • Resources and infrastrcuture (development) (RaU)
  • Evaluation of Treatments and Therapeutic Interventions (RaU)
    • Pharmaceuticals (RaU)
    • Cellular and gene therapies (RaU)
    • Medical devices (RaU)
    • Surgery (RaU)
    • Radiotherapy (RaU)
    • Psychological and behavioural (RaU)
    • Physical (RaU)
    • Complementary (RaU)
    • Resources and infrastrcuture (evaluation) (RaU)
  • Management of Diseases and Conditions (RaU)
    • Individual care needs (RaU)
    • End of life care (RaU)
    • Management and decision making (RaU)
    • Resources and infrastructure (management) (RaU)
  • Health and Social Care Services Research (RaU)
    • Organisation and delivery of services (RaU)
    • Healthe and welfare economics (RaU)
    • Policy ethics and research governance (RaU)
    • Research design and methodologies (RaU)
    • Resources and infrastructure (health services) (RaU)
• Reproductive Health and Childbirth
  • Underpinning Research (RHaC)
    • Normal biological development and functioning (RHaC)
    • Psychological and socioeconomic processes (RHaC)
    • Chemical and physical sciences (RHaC)
    • Methodologies and measurements (RHaC)
    • Resources and infrastructure (underpinning) (RHaC)
  • Aetiology (RHaC)
    • Biological and endogenous factors (RHaC)
    • Factors relating to physical environment (RHaC)
    • Psychological social and economic factors (RHaC)
    • Surveillance and distribution (RHaC)
    • Research design and methodologies (RHaC)
    • Resources and infrastructure (aetiology) (RHaC)
  • Prevention of Disease and Conditions and Promotion of Well-being (RHaC)
    • Primary prevention interventions to modify behaviours or promote well-being (RHaC)
    • Interventions to alter physical and biological environmental risks (RHaC)
    • Nutrition and chemoprevention (RHaC)
    • Vaccines (RHaC)
    • Resources and infrastructure (prevention) (RHaC)
  • Detection Screening and Diagnosis (RHaC)
    • Discovery and preclinical testing of markers and technologies (RHaC)
    • Evaluation of markers and technologies (RHaC)
    • Influences and impact (RHaC)
    • Population screening (RHaC)
    • Resources and infrastructure (detection) (RHaC)
  • Development of Treatments and Therapeutic Interventions (RHaC)
    • Pharmaceuticals (RHaC)
    • Cellular and gene therapies (RHaC)
    • Medical devices (RHaC)
    • Surgery (RHaC)
    • Radiotherapy (RHaC)
    • Psychological and behavioural (RHaC)
    • Physical (RHaC)
    • Complementary (RHaC)
    • Resources and infrastrcuture (development) (RHaC)
  • Evaluation of Treatments and Therapeutic Interventions (RHaC)
    • Pharmaceuticals (RHaC)
    • Cellular and gene therapies (RHaC)
    • Medical devices (RHaC)
    • Surgery (RHaC)
    • Radiotherapy (RHaC)
    • Psychological and behavioural (RHaC)
    • Physical (RHaC)
    • Complementary (RHaC)
    • Resources and infrastrcuture (evaluation) (RHaC)
  • Management of Diseases and Conditions (RHaC)
    • Individual care needs (RHaC)
    • End of life care (RHaC)
    • Management and decision making (RHaC)
    • Resources and infrastructure (management) (RHaC)
  • Health and Social Care Services Research (RHaC)
    • Organisation and delivery of services (RHaC)
    • Healthe and welfare economics (RHaC)
    • Policy ethics and research governance (RHaC)
    • Research design and methodologies (RHaC)
    • Resources and infrastructure (health services) (RHaC)
• Respiratory
  • Underpinning Research (Resp)
    • Normal biological development and functioning (Resp)
    • Psychological and socioeconomic processes (Resp)
    • Chemical and physical sciences (Resp)
    • Methodologies and measurements (Resp)
    • Resources and infrastructure (underpinning) (Resp)
  • Aetiology (Resp)
    • Biological and endogenous factors (Resp)
    • Factors relating to physical environment (Resp)
    • Psychological social and economic factors (Resp)
    • Surveillance and distribution (Resp)
    • Research design and methodologies (Resp)
    • Resources and infrastructure (aetiology) (Resp)
  • Prevention of Disease and Conditions and Promotion of Well-being (Resp)
    • Primary prevention interventions to modify behaviours or promote well-being (Resp)
    • Interventions to alter physical and biological environmental risks (Resp)
    • Nutrition and chemoprevention (Resp)
    • Vaccines (Resp)
    • Resources and infrastructure (prevention) (Resp)
  • Detection Screening and Diagnosis (Resp)
    • Discovery and preclinical testing of markers and technologies (Resp)
    • Evaluation of markers and technologies (Resp)
    • Influences and impact (Resp)
    • Population screening (Resp)
    • Resources and infrastructure (detection) (Resp)
  • Development of Treatments and Therapeutic Interventions (Resp)
    • Pharmaceuticals (Resp)
    • Cellular and gene therapies (Resp)
    • Medical devices (Resp)
    • Surgery (Resp)
    • Radiotherapy (Resp)
    • Psychological and behavioural (Resp)
    • Physical (Resp)
    • Complementary (Resp)
    • Resources and infrastrcuture (development) (Resp)
  • Evaluation of Treatments and Therapeutic Interventions (Resp)
    • Pharmaceuticals (Resp)
    • Cellular and gene therapies (Resp)
    • Medical devices (Resp)
    • Surgery (Resp)
    • Radiotherapy (Resp)
    • Psychological and behavioural (Resp)
    • Physical (Resp)
    • Complementary (Resp)
    • Resources and infrastrcuture (evaluation) (Resp)
  • Management of Diseases and Conditions (Resp)
    • Individual care needs (Resp)
    • End of life care (Resp)
    • Management and decision making (Resp)
    • Resources and infrastructure (management) (Resp)
  • Health and Social Care Services Research (Resp)
    • Organisation and delivery of services (Resp)
    • Healthe and welfare economics (Resp)
    • Policy ethics and research governance (Resp)
    • Research design and methodologies (Resp)
    • Resources and infrastructure (health services) (Resp)
• Skin
  • Underpinning Research (Skin)
    • Normal biological development and functioning (Skin)
    • Psychological and socioeconomic processes (Skin)
    • Chemical and physical sciences (Skin)
    • Methodologies and measurements (Skin)
    • Resources and infrastructure (underpinning) (Skin)
  • Aetiology (Skin)
    • Biological and endogenous factors (Skin)
    • Factors relating to physical environment (Skin)
    • Psychological social and economic factors (Skin)
    • Surveillance and distribution (Skin)
    • Research design and methodologies (Skin)
    • Resources and infrastructure (aetiology) (Skin)
  • Prevention of Disease and Conditions and Promotion of Well-being (Skin)
    • Primary prevention interventions to modify behaviours or promote well-being (Skin)
    • Interventions to alter physical and biological environmental risks (Skin)
    • Nutrition and chemoprevention (Skin)
    • Vaccines (Skin)
    • Resources and infrastructure (prevention) (Skin)
  • Detection Screening and Diagnosis (Skin)
    • Discovery and preclinical testing of markers and technologies (Skin)
    • Evaluation of markers and technologies (Skin)
    • Influences and impact (Skin)
    • Population screening (Skin)
    • Resources and infrastructure (detection) (Skin)
  • Development of Treatments and Therapeutic Interventions (Skin)
    • Pharmaceuticals (Skin)
    • Cellular and gene therapies (Skin)
    • Medical devices (Skin)
    • Surgery (Skin)
    • Radiotherapy (Skin)
    • Psychological and behavioural (Skin)
    • Physical (Skin)
    • Complementary (Skin)
    • Resources and infrastrcuture (development) (Skin)
  • Evaluation of Treatments and Therapeutic Interventions (Skin)
    • Pharmaceuticals (Skin)
    • Cellular and gene therapies (Skin)
    • Medical devices (Skin)
    • Surgery (Skin)
    • Radiotherapy (Skin)
    • Psychological and behavioural (Skin)
    • Physical (Skin)
    • Complementary (Skin)
    • Resources and infrastrcuture (evaluation) (Skin)
  • Management of Diseases and Conditions (Skin)
    • Individual care needs (Skin)
    • End of life care (Skin)
    • Management and decision making (Skin)
    • Resources and infrastructure (management) (Skin)
  • Health and Social Care Services Research (Skin)
    • Organisation and delivery of services (Skin)
    • Healthe and welfare economics (Skin)
    • Policy ethics and research governance (Skin)
    • Research design and methodologies (Skin)
    • Resources and infrastructure (health services) (Skin)
• Stroke
  • Underpinning Research (Stroke)
    • Normal biological development and functioning (Stroke)
    • Psychological and socioeconomic processes (Stroke)
    • Chemical and physical sciences (Stroke)
    • Methodologies and measurements (Stroke)
    • Resources and infrastructure (underpinning) (Stroke)
  • Aetiology (Stroke)
    • Biological and endogenous factors (Stroke)
    • Factors relating to physical environment (Stroke)
    • Psychological social and economic factors (Stroke)
    • Surveillance and distribution (Stroke)
    • Research design and methodologies (Stroke)
    • Resources and infrastructure (aetiology) (Stroke)
  • Prevention of Disease and Conditions and Promotion of Well-being (Stroke)
    • Primary prevention interventions to modify behaviours or promote well-being (Stroke)
    • Interventions to alter physical and biological environmental risks (Stroke)
    • Nutrition and chemoprevention (Stroke)
    • Vaccines (Stroke)
    • Resources and infrastructure (prevention) (Stroke)
  • Detection Screening and Diagnosis (Stroke)
    • Discovery and preclinical testing of markers and technologies (Stroke)
    • Evaluation of markers and technologies (Stroke)
    • Influences and impact (Stroke)
    • Population screening (Stroke)
    • Resources and infrastructure (detection) (Stroke)
  • Development of Treatments and Therapeutic Interventions (Stroke)
    • Pharmaceuticals (Stroke)
    • Cellular and gene therapies (Stroke)
    • Medical devices (Stroke)
    • Surgery (Stroke)
    • Radiotherapy (Stroke)
    • Psychological and behavioural (Stroke)
    • Physical (Stroke)
    • Complementary (Stroke)
    • Resources and infrastrcuture (development) (Stroke)
  • Evaluation of Treatments and Therapeutic Interventions (Stroke)
    • Pharmaceuticals (Stroke)
    • Cellular and gene therapies (Stroke)
    • Medical devices (Stroke)
    • Surgery (Stroke)
    • Radiotherapy (Stroke)
    • Psychological and behavioural (Stroke)
    • Physical (Stroke)
    • Complementary (Stroke)
    • Resources and infrastrcuture (evaluation) (Stroke)
  • Management of Diseases and Conditions (Stroke)
    • Individual care needs (Stroke)
    • End of life care (Stroke)
    • Management and decision making (Stroke)
    • Resources and infrastructure (management) (Stroke)
  • Health and Social Care Services Research (Stroke)
    • Organisation and delivery of services (Stroke)
    • Healthe and welfare economics (Stroke)
    • Policy ethics and research governance (Stroke)
    • Research design and methodologies (Stroke)
    • Resources and infrastructure (health services) (Stroke)
• Generic Health Relevance
  • Underpinning Research (GHR)
    • Normal biological development and functioning (GHR)
    • Psychological and socioeconomic processes (GHR)
    • Chemical and physical sciences (GHR)
    • Methodologies and measurements (GHR)
    • Resources and infrastructure (underpinning) (GHR)
  • Aetiology (GHR)
    • Biological and endogenous factors (GHR)
    • Factors relating to physical environment (GHR)
    • Psychological social and economic factors (GHR)
    • Surveillance and distribution (GHR)
    • Research design and methodologies (GHR)
    • Resources and infrastructure (aetiology) (GHR)
  • Prevention of Disease and Conditions and Promotion of Well-being (GHR)
    • Primary prevention interventions to modify behaviours or promote well-being (GHR)
    • Interventions to alter physical and biological environmental risks (GHR)
    • Nutrition and chemoprevention (GHR)
    • Vaccines (GHR)
    • Resources and infrastructure (prevention) (GHR)
  • Detection Screening and Diagnosis (GHR)
    • Discovery and preclinical testing of markers and technologies (GHR)
    • Evaluation of markers and technologies (GHR)
    • Influences and impact (GHR)
    • Population screening (GHR)
    • Resources and infrastructure (detection) (GHR)
  • Development of Treatments and Therapeutic Interventions (GHR)
    • Pharmaceuticals (GHR)
    • Cellular and gene therapies (GHR)
    • Medical devices (GHR)
    • Surgery (GHR)
    • Radiotherapy (GHR)
    • Psychological and behavioural (GHR)
    • Physical (GHR)
    • Complementary (GHR)
    • Resources and infrastrcuture (development) (GHR)
  • Evaluation of Treatments and Therapeutic Interventions (GHR)
    • Pharmaceuticals (GHR)
    • Cellular and gene therapies (GHR)
    • Medical devices (GHR)
    • Surgery (GHR)
    • Radiotherapy (GHR)
    • Psychological and behavioural (GHR)
    • Physical (GHR)
    • Complementary (GHR)
    • Resources and infrastrcuture (evaluation) (GHR)
  • Management of Diseases and Conditions (GHR)
    • Individual care needs (GHR)
    • End of life care (GHR)
    • Management and decision making (GHR)
    • Resources and infrastructure (management) (GHR)
  • Health and Social Care Services Research (GHR)
    • Organisation and delivery of services (GHR)
    • Healthe and welfare economics (GHR)
    • Policy ethics and research governance (GHR)
    • Research design and methodologies (GHR)
    • Resources and infrastructure (health services) (GHR)
• Other
  • Underpinning Research (Other)
    • Normal biological development and functioning (Other)
    • Psychological and socioeconomic processes (Other)
    • Chemical and physical sciences (Other)
    • Methodologies and measurements (Other)
    • Resources and infrastructure (underpinning) (Other)
  • Aetiology (Other)
    • Biological and endogenous factors (Other)
    • Factors relating to physical environment (Other)
    • Psychological social and economic factors (Other)
    • Surveillance and distribution (Other)
    • Research design and methodologies (Other)
    • Resources and infrastructure (aetiology) (Other)
  • Prevention of Disease and Conditions and Promotion of Well-being (Other)
    • Primary prevention interventions to modify behaviours or promote well-being (Other)
    • Interventions to alter physical and biological environmental risks (Other)
    • Nutrition and chemoprevention (Other)
    • Vaccines (Other)
    • Resources and infrastructure (prevention) (Other)
  • Detection Screening and Diagnosis (Other)
    • Discovery and preclinical testing of markers and technologies (Other)
    • Evaluation of markers and technologies (Other)
    • Influences and impact (Other)
    • Population screening (Other)
    • Resources and infrastructure (detection) (Other)
  • Development of Treatments and Therapeutic Interventions (Other)
    • Pharmaceuticals (Other)
    • Cellular and gene therapies (Other)
    • Medical devices (Other)
    • Surgery (Other)
    • Radiotherapy (Other)
    • Psychological and behavioural (Other)
    • Physical (Other)
    • Complementary (Other)
    • Resources and infrastrcuture (development) (Other)
  • Evaluation of Treatments and Therapeutic Interventions (Other)
    • Pharmaceuticals (Other)
    • Cellular and gene therapies (Other)
    • Medical devices (Other)
    • Surgery (Other)
    • Radiotherapy (Other)
    • Psychological and behavioural (Other)
    • Physical (Other)
    • Complementary (Other)
    • Resources and infrastrcuture (evaluation) (Other)
  • Management of Diseases and Conditions (Other)
    • Individual care needs (Other)
    • End of life care (Other)
    • Management and decision making (Other)
    • Resources and infrastructure (management) (Other)
  • Health and Social Care Services Research (Other)
    • Organisation and delivery of services (Other)
    • Healthe and welfare economics (Other)
    • Policy ethics and research governance (Other)
    • Research design and methodologies (Other)
    • Resources and infrastructure (health services) (Other)

Persons

Chester, John

Pickles, Timothy

Share link

Last updated on 2016-11-11 at 09:27